SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : URMD -- Huge market potential -- Ignore unavailable to you. Want to Upgrade?


To: Jeff Clegg who wrote (130)11/10/1997 9:40:00 AM
From: Joe Sing  Read Replies (2) | Respond to of 369
 
Hi Jeff:

Sour Grapes? NOPE, Just Sour Sales! Sour Revenues! Sour Earnings! Sour Profits! Sour Stock Performance! Sour Sour Sour All The Way Around (but not grapes!)

A few days ago, you wrote:
<URMD should be able to sell an easy 4,000 units in the U.S. alone>

Oh, where to begin???? Perhaps with the phrase, "...should be able to sell... "????

I think I've heard these hypotheticals before from our dear friend, Mr. Simon. In fact I recall that Uromed " ...should be able to sell... " $40 million in Reliance Inserts. The size of the incontinence market hasn't shrunk since that estimate; only their sales have!

#2) In regards to " ...$70 million in cash ..."; how much longer will URMD have this cash????? .... Let's see .... hmmmmm ... I remember not so long ago when that number was $93 million in cash; now it's only $70 million; next it will be down to a few million less and so on and so on and so on and so on.

#3) I agree with you. This CaverMap doo hicky has a lot of "potential" - as of course did the Reliance Insert, MiniGuard and the J&J doo hicky before it - but I DO NOT SEE ANY SALES !!!!!!!!!!!!

simply: SHOW ME THE MONEY !!!!!!!!!!

Good luck Jeff. I wish you well, but I've seen this nonsense too many times before to fall into the same trap again.